Screen Smart

The Colorectal Cancer Alliance's Screen Smart initiative empowers stakeholders with data-driven insights for smarter colorectal cancer screening decisions.

The Alliance's Screen Smart project logo, which includes the words data, access, and adherence.

Navigating a complex landscape

The Alliance launched Screen Smart in 2024, serving as a convener and thought leader to provide critical data and insights on data, access, and adherence in colorectal cancer screening. 

Our goals

To address these challenges, the Colorectal Cancer Alliance’s Screen Smart initiative focuses on three core goals: 

A blue icon of a magnifying glass over data points.

Share insights

Clarify the screening landscape by sharing data-driven insights on current and emerging screening modalities. 

An icon of a lock unlocked and a check mark.

Address barriers

Improve access and adoption by identifying and addressing barriers to equitable implementation through expert panels and policy discussions. 

An icon of a doctor.

Support users

Enhance data-driven decision-making by disseminating timely information on test approvals, performance metrics, and pipeline developments to support providers and patients.

The current situation

Over the past several decades, research in colorectal cancer prevention and early detection has led to the development of a growing number of screening modalities. In recent years, innovation in this space has accelerated rapidly, introducing new technologies and approaches. However, this progress has also created a complex and often confusing landscape for both healthcare professionals and patients. The proliferation of options — combined with limited head-to-head comparisons and 

DDW_2024_groupphoto

inconsistent data — has made it more difficult to make informed decisions about screening. Additionally, new barriers have emerged around equitable access and adoption of the latest screening tests.

Our progress

In 2024, the Colorectal Cancer Alliance hosted a discussion during Digestive Disease Week to address colorectal cancer screening tests. They collected data and developed a framework for evaluating various screening options, followed by discussions with medical directors from screening test companies. The 2025 Screen Smart discussion emphasized emerging technologies, adherence strategies based on modeling studies, and anticipated challenges related to access in screening.

Looking ahead

The 2025 Screen Smart discussion culminated in a forthcoming paper drawing upon insights from 2024, as well. The Alliance will leverage these findings to develop plain-language tools for patients and to create comprehensive educational resources for healthcare providers. Through these efforts, the Alliance aims to generate actionable insights that empower healthcare providers with cutting-edge knowledge and equip patient advocates with the tools they need to drive improvements in screening access, adherence, and outcomes.

2025 Screen Smart Dinner Advisory Committee

The advisory committee is comprised of dedicated individuals who are passionate about savings lives by increasing colorectal cancer screening rates.  

Committee Chair

Michael Sapienza

Chief Executive Officer, Colorectal Cancer Alliance

Co-Chair

Djenaba Joseph, MD, MPH

CAPT., U.S. Public Service Centers for Disease Control 

Co-Chair

Richard Wender, MD

Professor and Chair Family Medicine and Community Health, University of Pennsylvania

Member

Pam G. Traxel

Senior Vice President, ACS CAN

Member

Lee Dranikoff, BA, MA, JD

Patient Representative, Chair of the Board of the Colorectal Cancer Alliance, Founder of Practical Strategy